ITGA4 and acute lymphoblastic leukemia: Furthermore, they provided strong evidence for the chemoprotective function of integrin α4 showing that drug resistance of BCP-ALL in vivo was overcome by either ITGA4 gene knock-out or α4 blockade using the humanized anti-α4 monoclonal antibody natalizumab (74).